Works by Fathalipour, Mohammad


Results: 29
    1
    2
    3
    4

    Efficacy and tolerability of fourteen-day sequential quadruple regimen: pantoprazole, bismuth, amoxicillin, metronidazole and or furazolidone as first-line therapy for eradication of helicobacter pylori: A randomized, double-blind clinical trial.

    Published in:
    Turkish Journal of Gastroenterology, 2019, v. 30, p. S388, doi. 10.5152/tjg.2019.050919
    By:
    • Mansour-ghanaei, Fariborz;
    • Samadi, Alireza;
    • Joukar, Farahnaz;
    • Fakheri, Hafez Tirgar;
    • Hassanipour, Soheil;
    • Rezamand, Gholamreza;
    • Fathalipour, Mohammad
    Publication type:
    Article
    5
    6
    7
    8
    9
    10
    11
    12
    13
    15

    The clinical effect of Nano micelles containing curcumin as a therapeutic supplement in patients with COVID-19 and the immune responses balance changes following treatment: A structured summary of a study protocol for a randomised controlled trial.

    Published in:
    2020
    By:
    • Hassaniazad, Mehdi;
    • Inchehsablagh, Behnaz Rahnama;
    • Kamali, Hossein;
    • Tousi, Abdolali;
    • Eftekhar, Ebrahim;
    • Jaafari, Mahmoud Reza;
    • Fathalipour, Mohammad;
    • Nikoofal-Sahlabadi, Sara;
    • Gouklani, Hamed;
    • Alizade, Hesam;
    • Nikpoor, Amin Reza
    Publication type:
    Letter
    16
    17
    18
    19

    A triple‐blind, placebo‐controlled, randomized clinical trial to evaluate the effect of curcumin‐containing nanomicelles on cellular immune responses subtypes and clinical outcome in COVID‐19 patients.

    Published in:
    Phytotherapy Research, 2021, v. 35, n. 11, p. 6417, doi. 10.1002/ptr.7294
    By:
    • Hassaniazad, Mehdi;
    • Eftekhar, Ebrahim;
    • Inchehsablagh, Behnaz Rahnama;
    • Kamali, Hossein;
    • Tousi, Abdolali;
    • Jaafari, Mahmoud Reza;
    • Rafat, Milad;
    • Fathalipour, Mohammad;
    • Nikoofal‐Sahlabadi, Sara;
    • Gouklani, Hamed;
    • Alizade, Hesam;
    • Nikpoor, Amin Reza
    Publication type:
    Article
    20

    EFFICACY AND TOLERABILITY OF FOURTEEN-DAY SEQUENTIAL QUADRUPLE REGIMEN: PANTOPRAZOLE, BISMUTH, AMOXICILLIN, METRONIDAZOLE AND OR FURAZOLIDONE AS FIRST-LINE THERAPY FOR ERADICATION OF HELICOBACTER PYLORI: A RANDOMIZED, DOUBLE-BLIND CLINICAL TRIAL.

    Published in:
    EXCLI Journal, 2019, v. 18, p. 644, doi. 10.17179/excli2019-1613
    By:
    • Mansour-Ghanaei, Fariborz;
    • Samadi, Alireza;
    • Joukar, Farahnaz;
    • Fakheri, Hafez Tirgar;
    • Hassanipour, Soheil;
    • Ashoobi, Mohammad Taghi;
    • Soltanipour, Soheil;
    • Alizadeh, Ahmad;
    • Rezamand, Gholamreza;
    • Fathalipour, Mohammad
    Publication type:
    Article
    21
    22
    23
    24
    25
    26
    27
    28
    29